Milliken Healthcare expands via acquisition see more
Milliken & Company, a global innovation company with more than a century of performance and protective textile, specialty chemical and floor covering expertise, announces the acquisition of Andover Healthcare, a leading manufacturer of cohesive bandages and compression systems spanning healthcare, animal health and sports medicine markets. Joining Milliken Healthcare Products, LLC, Milliken & Company’s dedicated healthcare business, the acquisition strategically aligns two respected brands in patient care, bringing streamlined, comprehensive and innovative solutions to healthcare providers.
Milliken and Andover Healthcare share a commitment to making a positive impact on the world with high quality, innovative and patient-driven products.
“Andover Healthcare is a natural fit for Milliken. We are equally committed to improving the patient healing experience through innovative solutions, and our shared focus on ethics and integrity unites us culturally,” commented Halsey Cook, Milliken & Company president and CEO. “Our combined expertise and common drive to create innovative solutions invite us to set the bar for comprehensive patient care that helps create a healthier future.”
Headquartered in Portsmouth, New Hampshire, family-owned Andover Healthcare has been manufacturing healthcare solutions since 1976. The company is responsible for many notable developments in healthcare products, including a latex-free bandage and cohesive bandages with controlled compression. Its portfolio complements Milliken Healthcare’s offering of award-winning Active Fluid Management dressings for wound and burn care.
“Joining Milliken is the right progression for Andover Healthcare to usher in its next level of growth,” shared Andover Healthcare founder and CEO, Tom Murphy. “We look forward to serving our customers at a greater capacity with the research, design and manufacturing capabilities as well as trusted brand recognition that Milliken brings.”
About Milliken Healthcare Products, LLC
Milliken Healthcare Products, LLC brings innovative textiles to the healthcare market with the purpose to create a healthier future. Setting a high bar of excellence, its award-winning solutions redefine how textiles can function to improve the patient healing experience for wound and burn care through solutions that increase efficiency, reduce waste and improve cost. Milliken Healthcare Products, LLC is a subsidiary of Milliken & Company, a global manufacturer with expertise spanning specialty chemicals, floor covering, and performance and protective textiles, and leans on the company’s 153-year legacy of trust and innovation. Discover more at healthcare.milliken.com.
About Andover Healthcare
Since 1976, Andover Healthcare has strived to produce high quality products that fill a need for customers. From its roots as a manufacturer of sports medicine tape to its focus today on break-through, innovative products, Andover Healthcare medical tape, cohesive and wound bandages fill a gap in the healthcare, animal health and sports medicine industries. Andover Healthcare has been there to produce high quality, made in the USA products that improve the lives of its customers. Learn more at andoverhealthcare.com.
Medical device manufacturer launching new operations in the Upstate; life science boom continues see more
Medical device manufacturer launching new operations in the Upstate
Monday, October 16, 2017
COLUMBIA, S.C. – Arthrex, Inc., a global orthopedic medical device company, headquartered in Naples, Fla., is launching new manufacturing operations in Anderson County. The $69 million capital investment is expected to create more than 1,000 new jobs over the next several years.
With a corporate mission aimed at helping surgeons treat patients better, Arthrex is a leader in new product development and medical education in orthopedics. The company is a pioneer in the field of arthroscopy and has developed more than 11,000 innovative products and surgical procedures to advance minimally invasive orthopedics worldwide.
Located at 5500 Highway 76 in Sandy Springs, S.C., Arthrex will be constructing a new 200,000-square-foot facility to manufacture its innovative orthopedic devices and implants. Hiring for the new positions should begin in the next 12 to 18 months, and interested applicants should visit the company’s careers page online(link is external).
The Coordinating Council for Economic Development has approved job development credits related to this project.
“Arthrex is pleased to bring its innovative spirit and unique culture to Anderson County, S.C. and we look forward to leveraging the outstanding work done in the area to prepare future employees for high-level manufacturing jobs.” –Arthrex Vice President of Manufacturing Andy Owen
“South Carolina’s business-friendly climate continues to attract companies in every industry, and we’re proud to welcome Arthrex, Inc. to our growing business community. This a milestone for Anderson County, and we can’t wait to see the difference these jobs will make in the region.” –Gov. Henry McMaster
“Not only does our state excel in manufacturing, we’re also increasingly becoming a top choice for companies in the life sciences sector. Arthrex joins an impressive roster of life sciences firms that call South Carolina home, and we look forward to watching them grow in Anderson County for years to come.” –Secretary of Commerce Bobby Hitt
“We are absolutely thrilled to begin our partnership with Arthrex. Their precision medical products are used by medical professionals around the globe, and the fact that our citizens have been chosen to make them says volumes about the quality of our workforce as well as the skills training we provide.” –Anderson County Council Chairman Tommy Dunn
“This announcement takes our county in an exciting direction. Our goal of establishing a diverse economic base for our citizens is becoming a reality. The presence of this world-class company in our community speaks for who we are in Anderson, and we welcome them with open arms.” –Anderson County Councilman Tom Allen, District Four
FIVE FAST FACTS
- Arthrex is launching new manufacturing operations in Anderson County.
- $69 million capital investment to create more than 1,000 new jobs.
- Arthrex is a leading manufacturer of orthopedic medical devices.
- Located at 5500 Highway 76 in Sandy Springs, S.C., the company will be constructing a new 200,000-square-foot facility to manufacture its innovative orthopedic devices and implants.
- Hiring for the new positions should begin in the next 12 to 18 months, and interested applicants should visit the company’s careers page online.
Top speakers and brands are committing to attend SCBIO 2017 in Charleston this October; have you sig see more
BIO global CEO Jim Greenwood will join South Carolina Governor Henry McMaster as featured luncheon speakers on the first full day of SCBIO 2017 – the annual conference bringing top leaders and executives from organizations across the life sciences industry to Charleston, South Carolina October 24–26.
Mr. Greenwood will be addressing the gathering with a keynote presentation entitled “Global Trends for the Life Sciences Industry – and Implications for South Carolina” at lunch on October 25. South Carolina Governor Henry McMaster will follow with a presentation entitled “Life Sciences Powered by Public/Private Partnership – A Strategic View from the Statehouse.”
Dozens of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, and industry supporters from across America have already committed to attend SCBIO 2017 at Charleston’s Gaillard Auditorium, organizers confirmed today. Among the committed speakers and panelists are Nephron Pharmaceuticals CEO Lou Kennedy, MUSC President David Cole, Clemson University President Jim Clements, USC President Harris Pastides, Medpoint CEO Chuck Crumpton, Belimed CEO Joseph McDonald, AVX Health Division executive Robert Fairey and numerous others.
Themed “Building the Business of Life SCiences in SC”, the 2+ day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio ag and more. While space is limited and advance registration is required, interested attendees can still register at http://scbio2017.eventbrite.com.
SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.
SCBIO 2017 kicks off Tuesday evening with a Welcome Reception for conference registrants, speakers and sponsors on the rooftop terrace of the Grand Bohemian Hotel. Wednesday will feature a full day of sessions beginning at breakfast with a greeting by Charleston Mayor John Tecklenburg and continuing through an evening reception. The conference will wrap up Thursday at lunchtime.
“The life sciences industry has become a major driver of South Carolina’s economy,” noted South Carolina Secretary of Commerce Bobby Hitt recently. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.” SC Commerce is a Founding Partner of SCBIO and of the Conference.
Among the leading biotech industry brands participating in the conference are Nephron Pharmaceutical, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, Softbox, NCGS and SEMDA. All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are attending, as is Greenville Health System and economic development entities including SCRA, the Upstate SC Alliance, the Charleston Regional Development Alliance and SiMT.
As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.
Ty Kourlas posted an articleSouth Carolina Department of Commerce supporting public-private partnership to advance life sciences see more
COLUMBIA, S.C. – South Carolina’s life sciences industry has an annual economic impact of approximately $11.4 billion, according to a study commissioned by the S.C. Research Authority (SCRA) and S.C. Biotechnology Industry Organization (SCBIO) in partnership with the S.C. Department of Commerce (S.C. Commerce). Prepared by the University of South Carolina’s Darla Moore School of Business, the study finds that this growing sector has experienced an average annual employment growth rate of approximately 1.7 percent in the Palmetto State since 2005.
With a footprint of more than 15,000 employees and 400 firms in South Carolina, life sciences has developed into a critical component of the state’s economy and, as such, presents significant opportunities for economic growth. According to the study, the life sciences industry is associated with an employment multiplier of 2.9; meaning that, for every 10 jobs created within the industry, an additional 19 jobs are created elsewhere in the state.
Typically, these jobs are high-paying. The average direct job in South Carolina’s life sciences industry pays an annual total compensation of $78,658, which is approximately 95 percent higher than the state’s average annual compensation across all jobs.
“The life sciences industry has become a major driver of South Carolina’s economy,” said Secretary of Commerce Bobby Hitt. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.”
In July 2016, S.C. Commerce formed a partnership with SCBIO to determine the footprint of this sector in South Carolina. The first step in the partnership was to complete an economic impact study. Now that the study has been concluded and the scope of the state’s life sciences industry has been identified, the two organizations have forged a memorandum of understanding (MOU) that outlines shared goals and objectives designed to further catalyze and grow the life sciences industry in South Carolina.
A similar framework has been successfully implemented by S.C. Commerce with other industry sectors in recent years, including with the aerospace and logistics sectors. This MOU includes the creation of an unprecedented strategic plan for accelerating the development of the state’s burgeoning life sciences industry sector, and it’s expected to produce measurable results in the years ahead.
“The data generated by this economic study confirms the positive and significant impact that the life sciences industry is already having on the economy of South Carolina,” said SCBIO President and Chief Executive Officer Sam Konduros. “This data creates a solid foundation for future efforts and builds a clear and compelling case for why S.C. Commerce and SCBIO are deepening our partnership, implementing new joint strategies and synchronizing our collective efforts to further diversify and expand the economy of South Carolina through the power of the life sciences industry.”
Ty Kourlas posted an articleS.C. life science group, SCBIO, names new leader as young industry gains attention. see more
A longtime booster of the Upstate's economy is taking on a new challenge with a broader reach and a narrower focus: growing South Carolina's nascent life sciences industry.
SCBIO - a trade group representing biotechnology companies - has named Sam Konduros its next president and CEO, a move that comes as state officials increasingly eye the business as a target for South Carolina's economy.
Konduros, a former SCBIO board member, comes to the group from the Greenville Health System, where he ran an office that helped doctors take their inventions to market. Previously, he was the first president of the Upstate SC Alliance, the region's economic-development agency.
At Greenville-based SCBIO - short for the S.C. Biotechnology Industry Organization - he'll be tasked with helping to grow an industry that's only recently taken shape here.
The life sciences cover a broad mix of companies, from firms developing new drugs and researchers inventing medical devices to the manufacturers that make them. And while the state has a toehold into most corners of the sector, it's still relatively small here, employing about 17,500 workers statewide.
"It's a young industry that has the opportunity to grow into a powerful economic bookend for South Carolina," Konduros said.
The group's outgoing president, Wayne Roper, is credited with helping to map out its extent. His last task in the role is to finish a study backed by the S.C. Commerce Department outlining what life science companies are in the state, and where it's best poised to grow.
When he starts next month, Konduros's job will be to take those findings and bring them to fruition. The issues facing the life sciences industry, meantime, aren't so different from the state's technology sector as a whole.
New companies face challenges finding investments to fund their early operations before revenue rolls in. And the state is often overlooked amid regional powerhouses like Atlanta and North Carolina's Research Triangle.
Konduros says he'd like to turn that tide by marketing South Carolina to investors and industry executives - to sell them on the state's research universities and its emerging startup community. And he expects to take that message to the state's General Assembly, too.
Meantime, economic-development agencies have warmed to the sector recently. At the Commerce Department, the state Council on Competitiveness is now targeting biotech as a growth area for the state. And in the Lowcountry, the Charleston Regional Development Alliance is studying the sector as well.
"We're at a critical time for that growth," said Erin Ford, SCBIO's board chair. "When you have change it's an opportunity to really listen and take stock."
Read more at...